US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Korro Bio, Inc.

12.57

+1.038.93%

Post-market: 12.54-0.0300-0.24%17:58 EST

Volume:173.95K

Turnover:2.16M

Market Cap:118.38M

PE:-1.33

High:12.78

Open:11.64

Low:11.64

Close:11.54

52wk High:55.89

52wk Low:5.20

Shares:9.42M

Float Shares:5.74M

Volume Ratio:0.88

T/O Rate:3.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-9.4227

EPS(LYR):-9.3695

ROE:-63.46%

ROA:-29.16%

PB:1.20

PE(LYR):-1.34

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Korro Bio (KRRO) and AstraZeneca (AZN)

Korro Bio Shares Rise After Piper Sandler, HC Wainwright Upgrades

MT Newswires Live

Korro Bio Inc : H.c. Wainwright Raises to Buy From Neutral

THOMSON REUTERS

Korro Bio upgraded to Buy from Neutral at Chardan

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Pfizer (PFE) and Alpha Teknova (TKNO)

U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro Bio

Korro Bio Inc : Piper Sandler Raises to Overweight From Neutral; Raises Target Price to $30 From $11

THOMSON REUTERS

Korro Bio upgraded to Overweight from Neutral at Piper Sandler

Korro Bio Raised to Overweight From Neutral by Cantor Fitzgerald

Analysts Conflicted on These Healthcare Names: Korro Bio (KRRO), Kazia Therapeutics (KZIA) and AbbVie (ABBV)

Korro Bio : Oppenheimer Raises to Outperform From Perform

THOMSON REUTERS

Korro Bio upgraded to Overweight from Neutral at Cantor Fitzgerald

Korro Bio price target raised to $10 from $7 at Clear Street

Korro Bio Inc. Releases Overview of KRRO-121 RNA Editing Therapy for Ammonia Control

Korro Bio Showcases KRRO-121 RNA Editing Program Progress

Korro Bio Hosts Virtual Analyst Day to Spotlight KRRO-121 for Hyperammonemia

Korro Bio Updates Pipeline, Terminates KRRO-110 REWRITE Trial

Korro Bio Unveils Pipeline Advancements in RNA Editing for Genetic Medicines

Korro Bio Boosts Executive Pay and Severance in New Agreement

Korro Bio Early Trial Results Fall Short; Stock Hits New Low

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KRRO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KRRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","market":"US","secType":"STK","nameCN":"Korro Bio, Inc.","latestPrice":12.57,"timestamp":1770411600000,"preClose":11.54,"halted":0,"volume":173947,"hourTrading":{"tag":"盘后","latestPrice":12.54,"preClose":12.57,"latestTime":"17:58 EST","volume":11246,"amount":141912.32,"timestamp":1770418720664,"change":-0.03,"changeRate":-0.002387,"amplitude":0.019093},"delay":0,"changeRate":0.08925476603119595,"floatShares":5744014,"shares":9417295,"eps":-9.422738,"marketStatus":"Market Closed","change":1.03,"latestTime":"02-06 16:00:00 EST","open":11.64,"high":12.78,"low":11.64,"amount":2162916.487874,"amplitude":0.098787,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.422738,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1570075200000,"exchange":"NASDAQ","adjPreClose":11.54,"preHourTrading":{"tag":"盘前","latestPrice":11.65,"preClose":11.54,"latestTime":"09:20 EST","volume":159,"amount":1944.6599939999999,"timestamp":1770387653217,"change":0.11,"changeRate":0.009532,"amplitude":0.051127},"postHourTrading":{"tag":"盘后","latestPrice":12.54,"preClose":12.57,"latestTime":"17:58 EST","volume":11246,"amount":141912.32,"timestamp":1770418720664,"change":-0.03,"changeRate":-0.002387,"amplitude":0.019093},"volumeRatio":0.8779040201037417,"impliedVol":1.5308,"impliedVolPercentile":0.76},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRRO\",,,,,undefined,":{"symbol":"KRRO","floatShares":5744014,"roa":"-29.16%","roe":"-63.46%","lyrEps":-9.369477,"volumeRatio":0.8779040201037417,"shares":9417295,"dividePrice":0,"high":12.78,"amplitude":0.098787,"preClose":11.54,"low":11.64,"week52Low":5.2044,"pbRate":"1.20","psRate":"16.06","week52High":55.89,"institutionHeld":0,"latestPrice":12.57,"eps":-9.422738,"divideRate":0,"volume":173947,"delay":0,"ttmEps":-9.422738,"open":11.64,"prevYearClose":8.01,"prevWeekClose":13.33,"prevMonthClose":13.33,"prevQuarterClose":8.01,"fiveDayClose":13.33,"twentyDayClose":9.15,"sixtyDayClose":32.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"KRRO","fiscalQuarterEnding":"2025/09","expectedEps":-2.61,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.92},{"market":"US","date":"2025-08-12","symbol":"KRRO","fiscalQuarterEnding":"2025/06","expectedEps":-2.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-2.74},{"market":"US","date":"2025-05-07","symbol":"KRRO","fiscalQuarterEnding":"2025/03","expectedEps":-2.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-2.49},{"market":"US","date":"2025-03-18","symbol":"KRRO","fiscalQuarterEnding":"2024/12","expectedEps":-2.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-2.26},{"market":"US","date":"2024-11-12","symbol":"KRRO","fiscalQuarterEnding":"2024/09","expectedEps":-2.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-2.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1,"buy":0.4,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1769749200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KRRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KRRO","date":"2026-02-06","current":-1.334007,"percent":0.903882,"low":-8.894386,"twenty":-5.647115,"median":-4.062285,"eighty":-1.591885,"high":-0.562373,"avg":-3.87985,"sd":2.042328,"marketCap":108675584},"quantilePoints":[{"date":"2023-11-10","current":-4.581336,"twenty":-4.600294,"median":-4.593185,"eighty":-4.586076,"marketCap":328848276},{"date":"2023-11-17","current":-4.545683,"twenty":-4.815324,"median":-4.662668,"eighty":-4.586076,"marketCap":326289146},{"date":"2023-11-24","current":-4.263806,"twenty":-4.730727,"median":-4.581336,"eighty":-4.305029,"marketCap":306056020},{"date":"2023-12-01","current":-4.669353,"twenty":-4.669353,"median":-4.511145,"eighty":-4.263806,"marketCap":335166130},{"date":"2023-12-08","current":-5.29327,"twenty":-5.459276,"median":-4.605034,"eighty":-4.305029,"marketCap":379950915},{"date":"2023-12-15","current":-5.927214,"twenty":-5.596315,"median":-4.70004,"eighty":-4.344024,"marketCap":425455455},{"date":"2023-12-22","current":-5.775692,"twenty":-5.775692,"median":-5.29327,"eighty":-4.447639,"marketCap":414579150},{"date":"2023-12-29","current":-5.477103,"twenty":-5.763659,"median":-5.468189,"eighty":-4.46502,"marketCap":393146432},{"date":"2024-01-05","current":-5.57069,"twenty":-5.744941,"median":-5.477103,"eighty":-4.490422,"marketCap":399864150},{"date":"2024-01-12","current":-4.878811,"twenty":-5.700822,"median":-5.48323,"eighty":-4.552814,"marketCap":350201022},{"date":"2024-01-19","current":-4.570194,"twenty":-5.695474,"median":-5.467075,"eighty":-4.570194,"marketCap":328048548},{"date":"2024-01-26","current":-5.793518,"twenty":-5.702159,"median":-5.459276,"eighty":-4.579107,"marketCap":415858716},{"date":"2024-02-02","current":-5.903818,"twenty":-5.702159,"median":-5.475988,"eighty":-4.581336,"marketCap":423776026},{"date":"2024-02-09","current":-6.542219,"twenty":-5.793518,"median":-5.496043,"eighty":-4.605034,"marketCap":469600457},{"date":"2024-02-16","current":-6.005204,"twenty":-5.995177,"median":-5.561777,"eighty":-4.662668,"marketCap":431053553},{"date":"2024-02-23","current":-5.637539,"twenty":-6.009661,"median":-5.57459,"eighty":-4.668016,"marketCap":404662519},{"date":"2024-03-01","current":-5.381287,"twenty":-5.997182,"median":-5.57069,"eighty":-4.718452,"marketCap":386268768},{"date":"2024-03-08","current":-5.46819,"twenty":-5.954177,"median":-5.56679,"eighty":-4.734215,"marketCap":392506649},{"date":"2024-03-15","current":-6.597926,"twenty":-6.029715,"median":-5.57069,"eighty":-4.778761,"marketCap":473599099},{"date":"2024-03-22","current":-7.241897,"twenty":-6.148928,"median":-5.582946,"eighty":-4.827114,"marketCap":519823395},{"date":"2024-03-28","current":-8.749112,"twenty":-6.225581,"median":-5.594644,"eighty":-4.85118,"marketCap":710182879},{"date":"2024-04-05","current":-7.056213,"twenty":-6.445289,"median":-5.625283,"eighty":-4.87168,"marketCap":572766944},{"date":"2024-04-12","current":-7.760846,"twenty":-6.653602,"median":-5.643524,"eighty":-4.982426,"marketCap":629963419},{"date":"2024-04-19","current":-6.599635,"twenty":-6.850878,"median":-5.695474,"eighty":-5.142416,"marketCap":535705553},{"date":"2024-04-26","current":-6.686174,"twenty":-6.869775,"median":-5.765664,"eighty":-5.203025,"marketCap":542730135},{"date":"2024-05-03","current":-6.650761,"twenty":-6.964451,"median":-5.793518,"eighty":-5.219737,"marketCap":539855604},{"date":"2024-05-10","current":-6.269217,"twenty":-6.920952,"median":-5.915516,"eighty":-5.240905,"marketCap":508884843},{"date":"2024-05-17","current":-5.859151,"twenty":-6.869775,"median":-5.859151,"eighty":-5.274998,"marketCap":475317730},{"date":"2024-05-24","current":-5.495668,"twenty":-6.850878,"median":-5.84806,"eighty":-5.34608,"marketCap":445830598},{"date":"2024-05-31","current":-5.743893,"twenty":-6.8128,"median":-5.816278,"eighty":-5.412483,"marketCap":465967596},{"date":"2024-06-07","current":-5.114065,"twenty":-6.734223,"median":-5.793518,"eighty":-5.389162,"marketCap":414873438},{"date":"2024-06-14","current":-4.858019,"twenty":-6.694902,"median":-5.775692,"eighty":-5.295379,"marketCap":394101947},{"date":"2024-06-21","current":-4.102454,"twenty":-6.686174,"median":-5.755637,"eighty":-5.203025,"marketCap":332807503},{"date":"2024-06-28","current":-3.825833,"twenty":-6.685159,"median":-5.743893,"eighty":-5.149649,"marketCap":310366874},{"date":"2024-07-05","current":-4.380219,"twenty":-6.677519,"median":-5.73799,"eighty":-4.872237,"marketCap":355340861},{"date":"2024-07-12","current":-5.240945,"twenty":-6.652589,"median":-5.708166,"eighty":-4.858612,"marketCap":425166453},{"date":"2024-07-15","current":-5.618156,"twenty":-6.652132,"median":-5.702159,"eighty":-4.859205,"marketCap":455767311},{"date":"2024-08-02","current":-4.971182,"twenty":-6.651675,"median":-5.698816,"eighty":-4.859798,"marketCap":403282204},{"date":"2024-08-09","current":-4.113885,"twenty":-6.640451,"median":-5.660935,"eighty":-4.773204,"marketCap":333734802},{"date":"2024-08-16","current":-4.916432,"twenty":-6.613212,"median":-5.643524,"eighty":-4.733343,"marketCap":419376556},{"date":"2024-08-23","current":-4.817231,"twenty":-6.59861,"median":-5.625283,"eighty":-4.733343,"marketCap":410914634},{"date":"2024-08-30","current":-5.446229,"twenty":-6.597297,"median":-5.604672,"eighty":-4.737935,"marketCap":464568797},{"date":"2024-09-06","current":-4.658074,"twenty":-6.575014,"median":-5.590187,"eighty":-4.732471,"marketCap":397338364},{"date":"2024-09-13","current":-4.408437,"twenty":-6.520293,"median":-5.578489,"eighty":-4.665342,"marketCap":376044078},{"date":"2024-09-20","current":-4.196954,"twenty":-6.477243,"median":-5.57069,"eighty":-4.6075,"marketCap":358004377},{"date":"2024-09-27","current":-3.78816,"twenty":-6.457997,"median":-5.564005,"eighty":-4.555487,"marketCap":323133821},{"date":"2024-10-04","current":-3.412069,"twenty":-6.444854,"median":-5.520554,"eighty":-4.463176,"marketCap":291052909},{"date":"2024-10-11","current":-3.984381,"twenty":-6.396267,"median":-5.495668,"eighty":-4.391506,"marketCap":339871688},{"date":"2024-10-18","current":-8.722034,"twenty":-6.444854,"median":-5.494185,"eighty":-4.372675,"marketCap":743998188},{"date":"2024-10-25","current":-7.426973,"twenty":-6.575014,"median":-5.518326,"eighty":-4.380219,"marketCap":633528265},{"date":"2024-10-31","current":-6.633368,"twenty":-6.626621,"median":-5.552864,"eighty":-4.385863,"marketCap":565832892},{"date":"2024-11-08","current":-7.532715,"twenty":-6.647324,"median":-5.570133,"eighty":-4.416277,"marketCap":642548116},{"date":"2024-11-15","current":-5.302508,"twenty":-6.677519,"median":-5.57069,"eighty":-4.447647,"marketCap":465602621},{"date":"2024-11-22","current":-5.400663,"twenty":-6.652589,"median":-5.56679,"eighty":-4.448989,"marketCap":474221422},{"date":"2024-11-29","current":-5.554297,"twenty":-6.650761,"median":-5.56679,"eighty":-4.454222,"marketCap":487711719},{"date":"2024-12-06","current":-4.173725,"twenty":-6.633578,"median":-5.554297,"eighty":-4.447681,"marketCap":366486409},{"date":"2024-12-13","current":-4.690106,"twenty":-6.633368,"median":-5.55038,"eighty":-4.454222,"marketCap":411828797},{"date":"2024-12-20","current":-4.600486,"twenty":-6.599635,"median":-5.518326,"eighty":-4.476607,"marketCap":403959457},{"date":"2024-12-27","current":-4.39564,"twenty":-6.598268,"median":-5.495668,"eighty":-4.47213,"marketCap":385972394},{"date":"2025-01-03","current":-4.376436,"twenty":-6.597297,"median":-5.489358,"eighty":-4.431958,"marketCap":384286107},{"date":"2025-01-10","current":-4.013689,"twenty":-6.580078,"median":-5.474874,"eighty":-4.400759,"marketCap":352434016},{"date":"2025-01-17","current":-3.945407,"twenty":-6.549815,"median":-5.463733,"eighty":-4.371161,"marketCap":346438328},{"date":"2025-01-24","current":-4.049964,"twenty":-6.531256,"median":-5.447319,"eighty":-4.329948,"marketCap":355619225},{"date":"2025-01-31","current":-3.646675,"twenty":-6.482324,"median":-5.400974,"eighty":-4.264567,"marketCap":320207195},{"date":"2025-02-07","current":-3.864323,"twenty":-6.459999,"median":-5.376271,"eighty":-4.20066,"marketCap":339318449},{"date":"2025-02-14","current":-3.102554,"twenty":-6.448423,"median":-5.308909,"eighty":-4.176092,"marketCap":272429058},{"date":"2025-02-21","current":-3.056677,"twenty":-6.434147,"median":-5.302508,"eighty":-4.119313,"marketCap":268400706},{"date":"2025-02-28","current":-2.638451,"twenty":-6.340126,"median":-5.244267,"eighty":-4.093707,"marketCap":231677119},{"date":"2025-03-07","current":-2.367458,"twenty":-6.339446,"median":-5.203025,"eighty":-4.06287,"marketCap":207881733},{"date":"2025-03-14","current":-2.630983,"twenty":-6.269217,"median":-5.198397,"eighty":-4.049964,"marketCap":231021340},{"date":"2025-03-21","current":-2.460092,"twenty":-6.255885,"median":-5.114065,"eighty":-3.984381,"marketCap":205616953},{"date":"2025-03-28","current":-2.06468,"twenty":-6.247779,"median":-5.067789,"eighty":-3.960398,"marketCap":172568018},{"date":"2025-04-04","current":-1.656911,"twenty":-6.240921,"median":-5.016723,"eighty":-3.945407,"marketCap":138486304},{"date":"2025-04-11","current":-1.456959,"twenty":-6.236945,"median":-4.994706,"eighty":-3.88409,"marketCap":121774058},{"date":"2025-04-17","current":-1.512002,"twenty":-6.221793,"median":-4.974969,"eighty":-3.861976,"marketCap":126374620},{"date":"2025-04-25","current":-1.959087,"twenty":-6.206418,"median":-4.916432,"eighty":-3.824403,"marketCap":163742450},{"date":"2025-05-02","current":-2.066365,"twenty":-6.177673,"median":-4.874702,"eighty":-3.775951,"marketCap":172708852},{"date":"2025-05-09","current":-1.654409,"twenty":-6.170108,"median":-4.860984,"eighty":-3.687236,"marketCap":144613576},{"date":"2025-05-16","current":-1.555575,"twenty":-6.148652,"median":-4.836663,"eighty":-3.631696,"marketCap":135974324},{"date":"2025-05-23","current":-1.591026,"twenty":-6.130879,"median":-4.78968,"eighty":-3.512031,"marketCap":139073186},{"date":"2025-05-30","current":-1.260144,"twenty":-6.108373,"median":-4.78372,"eighty":-3.223328,"marketCap":110150471},{"date":"2025-06-06","current":-1.32675,"twenty":-6.061356,"median":-4.749297,"eighty":-3.117918,"marketCap":115972576},{"date":"2025-06-13","current":-1.50186,"twenty":-6.034499,"median":-4.735087,"eighty":-2.776295,"marketCap":131279078},{"date":"2025-06-20","current":-1.338568,"twenty":-6.030043,"median":-4.699133,"eighty":-2.705652,"marketCap":117005530},{"date":"2025-06-27","current":-1.325676,"twenty":-6.018574,"median":-4.677957,"eighty":-2.666335,"marketCap":115878671},{"date":"2025-07-03","current":-1.43418,"twenty":-6.003199,"median":-4.660916,"eighty":-2.628422,"marketCap":125363068},{"date":"2025-07-11","current":-1.459963,"twenty":-5.99384,"median":-4.62319,"eighty":-2.383248,"marketCap":127616786},{"date":"2025-07-18","current":-1.485746,"twenty":-5.986149,"median":-4.615445,"eighty":-2.328623,"marketCap":129870504},{"date":"2025-07-25","current":-1.708124,"twenty":-5.970205,"median":-4.600486,"eighty":-2.093296,"marketCap":149308822},{"date":"2025-08-01","current":-1.607141,"twenty":-5.940584,"median":-4.57486,"eighty":-1.999527,"marketCap":140481760},{"date":"2025-08-08","current":-1.703827,"twenty":-5.922535,"median":-4.545683,"eighty":-1.959761,"marketCap":148933203},{"date":"2025-08-15","current":-2.043579,"twenty":-5.895837,"median":-4.518539,"eighty":-1.949427,"marketCap":186691151},{"date":"2025-08-22","current":-2.112452,"twenty":-5.862962,"median":-4.454222,"eighty":-1.956391,"marketCap":192983056},{"date":"2025-08-29","current":-2.433175,"twenty":-5.854715,"median":-4.430175,"eighty":-1.959087,"marketCap":222282674},{"date":"2025-09-05","current":-2.887018,"twenty":-5.836969,"median":-4.402038,"eighty":-1.959087,"marketCap":263743510},{"date":"2025-09-12","current":-3.535145,"twenty":-5.825985,"median":-4.380219,"eighty":-1.962457,"marketCap":322953154},{"date":"2025-09-19","current":-3.414874,"twenty":-5.825526,"median":-4.355835,"eighty":-1.96751,"marketCap":311965797},{"date":"2025-09-26","current":-3.921657,"twenty":-5.806571,"median":-4.328858,"eighty":-1.980874,"marketCap":358262949},{"date":"2025-10-03","current":-4.69982,"twenty":-5.793518,"median":-4.339167,"eighty":-1.984924,"marketCap":429352085},{"date":"2025-10-10","current":-4.804672,"twenty":-5.786833,"median":-4.376436,"eighty":-1.99391,"marketCap":438930806},{"date":"2025-10-17","current":-4.995872,"twenty":-5.775692,"median":-4.38793,"eighty":-1.995034,"marketCap":456397885},{"date":"2025-10-24","current":-3.854839,"twenty":-5.770184,"median":-4.380219,"eighty":-2.0175,"marketCap":352158862},{"date":"2025-10-31","current":-3.746904,"twenty":-5.755637,"median":-4.355835,"eighty":-2.027132,"marketCap":342298414},{"date":"2025-11-07","current":-3.348057,"twenty":-5.743893,"median":-4.33284,"eighty":-2.032103,"marketCap":305861710},{"date":"2025-11-14","current":-0.67005,"twenty":-5.739166,"median":-4.291871,"eighty":-2.032103,"marketCap":61212417},{"date":"2025-11-21","current":-0.637995,"twenty":-5.73799,"median":-4.263806,"eighty":-1.99391,"marketCap":56409597},{"date":"2025-11-28","current":-0.607107,"twenty":-5.724273,"median":-4.259855,"eighty":-1.966499,"marketCap":53678581},{"date":"2025-12-05","current":-0.725333,"twenty":-5.715508,"median":-4.21043,"eighty":-1.954144,"marketCap":64131778},{"date":"2025-12-12","current":-0.841429,"twenty":-5.70918,"median":-4.195844,"eighty":-1.830004,"marketCap":74396630},{"date":"2025-12-19","current":-0.832908,"twenty":-5.703313,"median":-4.178846,"eighty":-1.734551,"marketCap":73643246},{"date":"2025-12-26","current":-0.895749,"twenty":-5.698148,"median":-4.175072,"eighty":-1.71414,"marketCap":79199450},{"date":"2026-01-02","current":-0.853145,"twenty":-5.689788,"median":-4.172125,"eighty":-1.703182,"marketCap":75432532},{"date":"2026-01-09","current":-0.974567,"twenty":-5.676061,"median":-4.119313,"eighty":-1.677034,"marketCap":86168249},{"date":"2026-01-16","current":-0.937288,"twenty":-5.665333,"median":-4.107026,"eighty":-1.662811,"marketCap":82872196},{"date":"2026-01-23","current":-1.11942,"twenty":-5.660609,"median":-4.081971,"eighty":-1.645845,"marketCap":98975770},{"date":"2026-01-30","current":-1.417648,"twenty":-5.657347,"median":-4.065967,"eighty":-1.61564,"marketCap":125344196},{"date":"2026-02-06","current":-1.229125,"twenty":-5.647115,"median":-4.062285,"eighty":-1.591885,"marketCap":108675584}],"updateTime":1770483682617},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KRRO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608883899","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Korro Bio (KRRO) and AstraZeneca (AZN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608883899","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608883899?lang=en_us&edition=fundamental","pubTime":"2026-02-01 23:11","pubTimestamp":1769958682,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN – Research Report), Korro Bio (KRRO – Research Re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-korro-bio-krro-and-astrazeneca-azn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-korro-bio-krro-and-astrazeneca-azn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823434583.USD","BK4588","XBI","LU0289739699.SGD","LABU","REGN","LU0320765992.SGD","LU1829250122.USD","BK4585","LU0058720904.USD","LU0882574055.USD","KRRO","LU2362541273.HKD","LU2106854487.HKD","LU0889565916.HKD","LU1917777945.USD","LU2023250504.SGD","LU1974910355.USD","LU2468319806.SGD","BK4581","LU0029874061.USD","HCSG","LU0823416689.USD","LU2362540622.SGD","LU0053666078.USD","LU0114720955.EUR","LU0128526141.USD","LU2089984988.USD","LU0823434740.USD","LU2237438978.USD","LU2417539215.USD","BK4568","LU2456880835.USD","LU0109394709.USD","LU2462157665.USD","AZN","BK4007","XLV","LU2362541513.USD","BK4137","BK4139","LU2236285917.USD"],"gpt_icon":0},{"id":"2607053004","title":"Korro Bio Shares Rise After Piper Sandler, HC Wainwright Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=2607053004","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607053004?lang=en_us&edition=fundamental","pubTime":"2026-01-30 03:52","pubTimestamp":1769716371,"startTime":"0","endTime":"0","summary":"Korro Bio  shares rose 13.5% in recent Thursday trading after Piper Sandler upgraded the stock to overweight from neutral and raised its price target to $30 per share from $11.HC Wainwright and Chardan also upgraded the stock to buy from neutral. HC Wainwright had a price target of $20 per share, while Chardan boosted its price target to $15 per share from $7.Trading volume stood at about 970,500 shares compared with a daily average of 533,201.Price: 13.31, Change: +1.62, Percent Change: +13.82","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2607857750","title":"Korro Bio Inc : H.c. Wainwright Raises to Buy From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2607857750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607857750?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:17","pubTimestamp":1769685468,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YU0JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2607700259","title":"Korro Bio upgraded to Buy from Neutral at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2607700259","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607700259?lang=en_us&edition=fundamental","pubTime":"2026-01-29 18:00","pubTimestamp":1769680815,"startTime":"0","endTime":"0","summary":"Chardan upgraded Korro Bio (KRRO) to Buy from Neutral with a $15 price target following the analyst day. The company says the company has “turned t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-upgraded-to-buy-from-neutral-at-chardan-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-upgraded-to-buy-from-neutral-at-chardan-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2607670276","title":"Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Pfizer (PFE) and Alpha Teknova (TKNO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607670276","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607670276?lang=en_us&edition=fundamental","pubTime":"2026-01-29 17:20","pubTimestamp":1769678447,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Korro Bio (KRRO – Research Report), Pfizer (PFE – Research Report...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-korro-bio-krro-pfizer-pfe-and-alpha-teknova-tkno-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-korro-bio-krro-pfizer-pfe-and-alpha-teknova-tkno-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0456855351.SGD","IE000M9KFDE8.USD","SG9999002232.USD","IE00BBT3K403.USD","LU0170899867.USD","LU0225771236.USD","BK4568","IE00BLSP4239.USD","LU0225284248.USD","LU0029874061.USD","SG9999013999.USD","BK4121","LU1066051498.USD","SG9999003800.SGD","SG9999011175.SGD","LU0321505868.SGD","LU1023059063.AUD","SG9999002224.SGD","SGXZ57979304.SGD","BK4588","BK4581","LU0306806265.USD","BK4007","LU0058720904.USD","LU1883839398.USD","LU1894683348.USD","XBI","TKNO","BK4539","IE0002270589.USD","IE00B19Z3581.USD","LU0985481810.HKD","LU0289739699.SGD","LU1057294990.SGD","LU0321505439.SGD","SG9999001176.USD","LU1066053197.SGD","IE00BLSP4452.SGD","BK4599","LU0868494617.USD","KRRO","SG9999001176.SGD","BK4592","LU0122379950.USD","PFE","BK4585","BK4139","IE00B19Z3B42.SGD","BK4550","LU0128526141.USD","LU0234572021.USD","BK4533","LU0306807586.USD","LU1894683264.USD","LABU","BK4534"],"gpt_icon":0},{"id":"2607087706","title":"U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087706","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607087706?lang=en_us&edition=fundamental","pubTime":"2026-01-29 15:54","pubTimestamp":1769673282,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro BioJan 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AG","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nL4N3YU0VD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIAV","META","LEVI","CHRW","BMI","MSFL","MSFT","NOW","SF","GEF","DHR","BRO","JKHY","CELH","ADP","07766","GLW","RJF","T","UMBF","RTX","TSLA","NOC","LII","MSFU","EFX","HLI","KRRO","TRU","TSDD","WSFS","IBM","PPG","SEIC","EAT","MSFO","SBUX","NVR","PB","MSCI","GD","MSFW","MSFX","TSII","LRCX","STEL","QCRH","AGNC","MSFY","MSFD"],"gpt_icon":0},{"id":"2607625770","title":"Korro Bio Inc : Piper Sandler Raises to Overweight From Neutral; Raises Target Price to $30 From $11","url":"https://stock-news.laohu8.com/highlight/detail?id=2607625770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607625770?lang=en_us&edition=fundamental","pubTime":"2026-01-29 14:25","pubTimestamp":1769667947,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT1QA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2607375721","title":"Korro Bio upgraded to Overweight from Neutral at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2607375721","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607375721?lang=en_us&edition=fundamental","pubTime":"2026-01-29 07:15","pubTimestamp":1769642116,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi upgraded Korro Bio (KRRO) to Overweight from Neutral with a price target of $30, up from $11. Published first ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-upgraded-to-overweight-from-neutral-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-upgraded-to-overweight-from-neutral-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2606485157","title":"Korro Bio Raised to Overweight From Neutral by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2606485157","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606485157?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:17","pubTimestamp":1769613420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 28, 2026 10:17 ET (15:17 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2606671787","title":"Analysts Conflicted on These Healthcare Names: Korro Bio (KRRO), Kazia Therapeutics (KZIA) and AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606671787","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606671787?lang=en_us&edition=fundamental","pubTime":"2026-01-28 22:20","pubTimestamp":1769610021,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Korro Bio (KRRO – Research Report), Kazia Therapeu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-korro-bio-krro-kazia-therapeutics-kzia-and-abbvie-abbv-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-korro-bio-krro-kazia-therapeutics-kzia-and-abbvie-abbv-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0689626769.HKD","LU1074936037.SGD","LU0738911758.USD","XBI","SG9999003800.SGD","LU1244550494.USD","LU1003077747.HKD","SG9999015986.USD","LU0965509101.SGD","IE0002270589.USD","XLV","IE00BN8TJ469.HKD","LU0122379950.USD","LU0211327993.USD","ABBV","IE00BBT3K403.USD","LU1934455863.HKD","LU1989771016.USD","LU1244550221.USD","LU1929549753.HKD","LU0211328371.USD","HCSG","IE00B19Z3B42.SGD","KZIA","LU0795875169.SGD","IE00BVYPNW00.USD","LU0949170772.SGD","LU1430594728.SGD","SG9999015978.USD","BK4585","IE0009355771.USD","LU1023059063.AUD","LU2087621335.USD","IE0004445239.USD","LU0553294199.USD","LU0417517546.SGD","LU1983299246.USD","IE00B2B36J28.USD","BK4559","LU1291159041.SGD","LU1732799900.SGD","IE00BSNM7G36.USD","BK4139","BK4533","LU0057025933.USD","LU0472753341.HKD","LU1551013425.SGD","IE00BLSP4452.SGD","KRRO","LABU"],"gpt_icon":0},{"id":"2606711281","title":"Korro Bio : Oppenheimer Raises to Outperform From Perform","url":"https://stock-news.laohu8.com/highlight/detail?id=2606711281","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606711281?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:26","pubTimestamp":1769606819,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nAZN4S5J62:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2606758050","title":"Korro Bio upgraded to Overweight from Neutral at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2606758050","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606758050?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:17","pubTimestamp":1769548657,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Steve Seedhouse upgraded Korro Bio (KRRO) to Overweight from Neutral with a $21 price target The upgrade reflects confide...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-upgraded-to-overweight-from-neutral-at-cantor-fitzgerald-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-upgraded-to-overweight-from-neutral-at-cantor-fitzgerald-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2606675809","title":"Korro Bio price target raised to $10 from $7 at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2606675809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606675809?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:15","pubTimestamp":1769548526,"startTime":"0","endTime":"0","summary":"Clear Street raised the firm’s price target on Korro Bio (KRRO) to $10 from $7 and keeps a Hold rating on the shares following the analyst day. The...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/korro-bio-price-target-raised-to-10-from-7-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/korro-bio-price-target-raised-to-10-from-7-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2606342735","title":"Korro Bio Inc. Releases Overview of KRRO-121 RNA Editing Therapy for Ammonia Control","url":"https://stock-news.laohu8.com/highlight/detail?id=2606342735","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606342735?lang=en_us&edition=fundamental","pubTime":"2026-01-27 23:30","pubTimestamp":1769527843,"startTime":"0","endTime":"0","summary":"Korro Bio Inc. published a document outlining the development of KRRO-121, a potential treatment for ammonia control in conditions such as urea cycle disorders and hepatic encephalopathy. The document includes scientific overviews, preclinical data, product profile information, and perspectives from clinicians and patients. The full document can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief on January 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL5wDdLx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2606733989","title":"Korro Bio Showcases KRRO-121 RNA Editing Program Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2606733989","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606733989?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:49","pubTimestamp":1769525355,"startTime":"0","endTime":"0","summary":"Korro Bio ( ($KRRO) ) has provided an announcement. On January 27, 2026, Korro Bio, Inc. held a virtual Analyst Day where management presented KRRO...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/korro-bio-showcases-krro-121-rna-editing-program-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/korro-bio-showcases-krro-121-rna-editing-program-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","PRGS","BK4505","IE0009354923.USD","KRRO","LU2065732104.USD","BK4097","RNA","BK4585"],"gpt_icon":0},{"id":"2604113257","title":"Korro Bio Hosts Virtual Analyst Day to Spotlight KRRO-121 for Hyperammonemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113257","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113257?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:02","pubTimestamp":1768914133,"startTime":"0","endTime":"0","summary":"Korro Bio Inc. will host a virtual Analyst Day on January 27, 2026, from 8 a.m. to 10 a.m. ET. The event will feature presentations from the company's management team, a leading clinical hepatologist, and a caregiver to discuss KRRO-121 for the potential treatment of hyperammonemia, as well as provide insights into ammonia-driven diseases and the challenges faced by those living with urea cycle disorders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Korro Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on January 20, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDLb0HCbY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","KRRO","SG9999014005.SGD","LU2210149790.SGD","BK4585","LU2095319765.USD","NDAQ","LU2210150020.SGD","SG9999014039.USD","BK4139","SG9999014013.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2603936397","title":"Korro Bio Updates Pipeline, Terminates KRRO-110 REWRITE Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2603936397","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603936397?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:33","pubTimestamp":1768512786,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Korro Bio ( ($KRRO) ). On January 15, 2026, Korro Bio, Inc. updated its corporate presentation for investors an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/korro-bio-updates-pipeline-terminates-krro-110-rewrite-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/korro-bio-updates-pipeline-terminates-krro-110-rewrite-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2603384959","title":"Korro Bio Unveils Pipeline Advancements in RNA Editing for Genetic Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2603384959","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603384959?lang=en_us&edition=fundamental","pubTime":"2026-01-16 03:27","pubTimestamp":1768505253,"startTime":"0","endTime":"0","summary":"Korro Bio Inc. has provided an update on its pipeline of RNA editing-based therapeutic candidates targeting rare and prevalent diseases. The company highlighted the progress of its lead asset, KRRO-121, aimed at treating hyperammonemia, with an update expected on January 27, 2026. Additional programs include efforts to repair pathogenic variants in Alpha-1 Antitrypsin Deficiency  and to develop allosteric activators for longevity, all utilizing GalNAc-based delivery for liver targeting. The presentation also outlined anticipated milestones for 2026 and described the company's emphasis on leveraging ADAR biology, machine learning, and advanced chemistry to drive drug discovery and development. Korro Bio reported a cash position of $102.5 million as of September 30, 2025, projecting a runway into the second half of 2027. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. Whi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL1kn4Xv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2592918197","title":"Korro Bio Boosts Executive Pay and Severance in New Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2592918197","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592918197?lang=en_us&edition=fundamental","pubTime":"2025-12-19 05:06","pubTimestamp":1766091973,"startTime":"0","endTime":"0","summary":"Korro Bio Inc. has entered into an amended and restated employment agreement with Jeffrey Cerio, effective December 15, 2025. The new agreement increases Dr. Cerio's annual base salary to $425,000 and enhances severance terms, providing nine months of salary in the event of termination without cause or resignation for good reason, and 12 months of salary in similar circumstances within the change in control period. Dr. Cerio has also been awarded a $100,000 cash bonus, payable in two installments—half on December 31, 2025, and half on or about June 30, 2026—contingent on continued service. Additionally, he has been granted 41,902 restricted stock units, vesting in two equal tranches on June 15, 2026, and December 15, 2026, subject to continued service.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL5LdXHy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2583524516","title":"Korro Bio Early Trial Results Fall Short; Stock Hits New Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2583524516","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583524516?lang=en_us&edition=fundamental","pubTime":"2025-11-14 03:26","pubTimestamp":1763061960,"startTime":"0","endTime":"0","summary":"Korro Bio shares drop after KRRO-110 trial in AATD misses protein goals; company cuts 34% of staff and shifts focus to liver-targeted programs.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/13/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/13/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/48846497/korro-bio-early-trial-results-fall-short-stock-hits-new-low","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/48846497/korro-bio-early-trial-results-fall-short-stock-hits-new-low","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4139","LU0154236417.USD","LU1093756168.USD","BK4081","KRRO","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4585","BK4007","BK4599","LU1093756325.SGD","BK4532","BK4588","HE"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":59,"code":"91000000","status":"200"}]}}